A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to safeguard public health:
The Pakistan Pharmaceutical Manufacturers Association (PPMA) strongly welcomes these landmark regulatory milestones, standing united with DRAP in this definitive victory for national patient safety and pharmaceutical innovation.
